[Pulmonary endarterectomy--the surgical treatment of chronic thromboembolic pulmonary hypertension]
Related Experiment Video
Updated: Aug 9, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
J Lindner1, P Jansa, J Kunstýr
1II. chirurgická klinika kardiovaskulární chirurgie 1, LF UK a VFN, Praha. lindner@seznam.cz
Insights
Pulmonary endarterectomy (PEA) offers a life-saving treatment for chronic thromboembolic pulmonary hypertension (CTEPH). This surgical intervention significantly improves patient survival and pulmonary function.
Area of Science:
- Cardiovascular Surgery
- Pulmonary Hypertension Research
- Medical Innovation
Context:
- Chronic thromboembolic pulmonary hypertension (CTEPH) presents a poor prognosis without effective treatment.
- Pulmonary artery endarterectomy (PEA) was introduced in the Czech Republic in 2004.
- Established collaboration with international experts in PEA.
Purpose:
- To implement and evaluate the efficacy of pulmonary artery endarterectomy (PEA) for surgically treatable CTEPH.
- To establish a specialized program for the complex diagnosis and treatment of CTEPH patients.
Summary:
- A modified reverse endarterectomy technique using deep hypothermic circulatory arrest was employed.
- Twelve CTEPH patients underwent surgery with zero mortality by September 2005.
- Significant improvements in hemodynamic parameters and 6-minute walking distance were observed post-surgery.
Impact:
- PEA is a viable treatment for CTEPH with surgically accessible obstruction.
- Centralized patient care enhances expertise in managing complex CTEPH cases.
- Multidisciplinary collaboration is crucial for successful CTEPH treatment programs.
Background:
Chronic thromboembolic pulmonary hypertension (CTEPH) in indicated cases can be successfully treated by the endarterectomy of pulmonary arteries (PEA). Symptomatically not treated CTEPH has highly unfavourable prognosis. Five years survival of patients with mean pulmonary pressure over 50 mmHg is only 10%. PEA was not available in the Czech Republic till 2004, when PEA program was initiated it the Cardiocenter of the General teaching hospital in Prague in collaboration with leading clinics in that field (Prof. Mayer, University of Mainz, BRD).
Methods And Results:
Up-to-date surgical technique, which in various modifications has been used at majority of clinics, was elaborated by Jamieson and Daily at University of California in San Diego. It is based on reverse endarterectomy performed during complete circulatory arrest with brain protection by deep hypothermia. Till September 2005 twelve patients were operated with zero mortality. In one patient a suture of atrial septum defect was necessary to perform along. Average time of the circulatory arrest was 45 minutes; duration of the extracorporal circulation was 334 minutes. Average duration of the operation was 450 minutes. Duration of the mechanical ventilation was in average 45.5 hours. After one month already haemodynamic parameters (mPA, CI, PVR) significantly improved or normalized and the average length in the test of six minutes walking increased by 132 meters.
Conclusion:
PEA represents a treatment method for patients with CTEPH and surgically accessible pulmonary artery obstruction. Centralized care of those patients is a rational necessity enabling to get maximum experience with complicated diagnostics and treatment of those patients. Multidisciplinary collaboration is the essential condition for the success of the program.
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Pulmonary Embolism III: Nursing Management
Pulmonary Embolism I: Introduction
Pulmonary Embolism I: Introduction
Peripheral Artery Disease III: Interprofessional Care
